SCHEMBL7823735

SCHEMBL7823735

CCC(C)c1nnc2ccccc2c1O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR3 P46089 1/20 0.42
TSHR P16473 1/20 0.42
ELANE P08246 5/20 0.38
TLR8 Q9NR97 1/20 0.37
TLR7 Q9NYK1 1/20 0.37
MPO P05164 1/20 0.36
ALDH1A1 P00352 2/20 0.35
CYP1A2 P05177 2/20 0.35
CYP2C19 P33261 2/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
MEN1 O00255 1/20 0.33
GBA1 P04062 1/20 0.33
GLA P06280 1/20 0.33
GAA P10253 1/20 0.33
MAPT P10636 1/20 0.33
KMT2A Q03164 1/20 0.33
HIF1A Q16665 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
TACR2 P21452 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7836460 0.80 GPR3 (0.42) GPR3TSHRELANETLR8TLR7
SCHEMBL12533983 0.70 GPR3 (0.47) GPR3TSHRELANETLR8TLR7
SCHEMBL20115779 0.69 PI4KA (0.44) TSHRALDH1A1CYP1A2CYP2C19SMN1; SMN2
SCHEMBL22124938 0.69 GPR3 (0.54) GPR3MPOALDH1A1CYP1A2CYP2C19
SCHEMBL28981702 0.68 GPR3 (0.59) GPR3ALDH1A1CYP1A2CYP2C19SMN1; SMN2
SCHEMBL14665250 0.67 TSHR (0.50) TSHRALDH1A1MEN1GAAMAPT
SCHEMBL7823737 0.67 GPR3 (0.42) GPR3TSHRTLR8TLR7ALDH1A1
SCHEMBL18721843 0.66 TSHR (0.39) TSHRELANETLR8TLR7ALDH1A1
SCHEMBL16077726 0.66 GPR3 (0.50) GPR3TSHRELANETLR8TLR7
SCHEMBL12386870 0.66 KDM4E (0.50) GPR3TSHRELANETLR8TLR7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0498723-B1 Nitrogen containing bicycle compounds, method for their preparation, their use as pharmaceutical and compositions containing them AVENTIS PHARMA SA (FR) 2001-09-19 EP disclosed
EP-0498721-B1 N-substituted quinoline derivatives, process for their preparation, their use as pharmaceuticals and pharmaceutical compositions containing them HOECHST MARION ROUSSEL INC (FR) 1999-12-22 EP disclosed
EP-0498722-B1 Bicyclic nitrogen compounds, their preparation, intermediates obtained, their use as pharmaceuticals and pharmaceutical compositions containing them ROUSSEL UCLAF (FR) 1997-07-30 EP disclosed
EP-0498723-A1 Nitrogen containing bicycle compounds, method for their preparation, their use as pharmaceutical and compositions containing them ROUSSEL UCLAF (FR) 1992-08-12 EP disclosed
EP-0498722-A1 Bicyclic nitrogen compounds, their preparation, intermediates obtained, their use as pharmaceuticals and pharmaceutical compositions containing them ROUSSEL UCLAF (FR) 1992-08-12 EP disclosed
EP-0498721-A1 N-substituted quinoline derivatives, process for their preparation, intermediates obtained, their use as pharmaceuticals and pharmaceutical compositions containing them ROUSSEL UCLAF (FR) 1992-08-12 EP disclosed